Moderna (MRNA) Net Margin (2017 - 2026)
Moderna (MRNA) reported Net Margin of 345.24% for Q1 2026, up 55383.0% year-over-year from N/an in Q1 2025, and down 183.38% quarter-over-quarter from 121.83% in Q4 2025.
Moderna (MRNA) Net Margin (2017 - 2026) Analysis & Trends
Moderna (MRNA) has 10 years of Net Margin data on file, last reported at 345.24% in Q1 2026.
- Net Margin for Q1 2026 came in at 345.24%, up 55383.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 143.55% (down 3568.0% YoY), and the FY2025 annual result was 145.16%, down 3512.0% from the prior year.
- Net Margin declined to 345.24% in Q1 2026 per MRNA's latest filing, from 121.83% in the prior quarter.
- Over five years, Net Margin peaked at 60.29% in Q1 2022 and troughed at 899.07% in Q1 2025.
- A 5-year average of 231.38% and a median of 115.94% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2024 and 2026: Net Margin sank 70784 bps in 2024, then jumped 55383 bps in 2026.
- A 5-year view of Net Margin shows it stood at 28.82% in 2022, then sank by 73 bps to 7.72% in 2023, then sank by 1602 bps to 115.94% in 2024, then slipped by 5 bps to 121.83% in 2025, then tumbled by 183 bps to 345.24% in 2026.
- Business Quant data shows MRNA's Net Margin at 345.24% in Q1 2026, 121.83% in Q4 2025, and 19.69% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | -345.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -345.24% |
| Dec 31, 2025 | -121.83% |
| Sep 30, 2025 | -19.69% |
| Jun 30, 2025 | -580.99% |
| Mar 31, 2025 | -899.07% |
| Dec 31, 2024 | -115.94% |
| Sep 30, 2024 | 0.70% |
| Jun 30, 2024 | -726.70% |
| Mar 31, 2024 | -703.59% |
| Dec 31, 2023 | 7.72% |
| Sep 30, 2023 | -198.25% |
| Jun 30, 2023 | -401.16% |
| Mar 31, 2023 | 4.24% |
| Dec 31, 2022 | 28.82% |
| Sep 30, 2022 | 31.00% |
| Jun 30, 2022 | 46.26% |
| Mar 31, 2022 | 60.29% |
| Dec 31, 2021 | 67.51% |
| Sep 30, 2021 | 67.08% |
| Jun 30, 2021 | 63.85% |